Literature DB >> 26396143

Understanding the Role of the Immune System in the Development of Cancer: New Opportunities for Population-Based Research.

Dominique S Michaud1, E Andres Houseman2, Carmen J Marsit3, Heather H Nelson4, John K Wiencke5, Karl T Kelsey6.   

Abstract

Understanding the precise role of the immune system in cancer has been hindered by the complexity of the immune response and challenges in measuring immune cell types in health and disease in the context of large epidemiologic studies. In this review, we present the rationale to study immunity in cancer and highlight newly available tools to further elucidate the epidemiologic factors driving individual variation in the immune response in cancer. Here, we summarize key studies that have evaluated the role of immunologic status on risk of cancer, discuss tools that have been used in epidemiologic studies to measure immune status, as well as new evolving methodologies where application to epidemiology is becoming more feasible. We also encourage further development of novel emerging technologies that will continue to enable prospective assessment of the dynamic and complex role played by the immune system in cancer susceptibility. Finally, we summarize characteristics and environmental factors that affect the immune response, as these will need to be considered in epidemiologic settings. Overall, we consider the application of a systems biologic approach and highlight new opportunities to understand the immune response in cancer risk. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 26396143     DOI: 10.1158/1055-9965.EPI-15-0681

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  10 in total

1.  Prospective Study of Human Polyomaviruses and Risk of Cutaneous Squamous Cell Carcinoma in the United States.

Authors:  Anala Gossai; Tim Waterboer; Heather H Nelson; Jennifer A Doherty; Angelika Michel; Martina Willhauck-Fleckenstein; Shohreh F Farzan; Brock C Christensen; Anne G Hoen; Ann E Perry; Michael Pawlita; Margaret R Karagas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02-11       Impact factor: 4.254

2.  Neutrophil-Lymphocyte Ratio as a Marker of Progression from Non-Dysplastic Barrett's Esophagus to Esophageal Adenocarcinoma: a Cross-Sectional Retrospective Study.

Authors:  Vinicius J Campos; Guilherme S Mazzini; José F Juchem; Richard R Gurski
Journal:  J Gastrointest Surg       Date:  2019-11-19       Impact factor: 3.452

Review 3.  PTEN-opathies: from biological insights to evidence-based precision medicine.

Authors:  Lamis Yehia; Joanne Ngeow; Charis Eng
Journal:  J Clin Invest       Date:  2019-01-07       Impact factor: 14.808

Review 4.  PTEN in Hereditary and Sporadic Cancer.

Authors:  Joanne Ngeow; Charis Eng
Journal:  Cold Spring Harb Perspect Med       Date:  2020-04-01       Impact factor: 6.915

5.  Distinct Epigenetic Effects of Tobacco Smoking in Whole Blood and among Leukocyte Subtypes.

Authors:  Dan Su; Xuting Wang; Michelle R Campbell; Devin K Porter; Gary S Pittman; Brian D Bennett; Ma Wan; Neal A Englert; Christopher L Crowl; Ryan N Gimple; Kelly N Adamski; Zhiqing Huang; Susan K Murphy; Douglas A Bell
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

6.  Differences of immune disorders between Alzheimer's disease and breast cancer based on transcriptional regulation.

Authors:  Wei Kong; Xiaoyang Mou; Jin Deng; Benteng Di; Ruxing Zhong; Shuaiqun Wang; Yang Yang; Weiming Zeng
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

Review 7.  Cancer Immunoprevention and Public Health.

Authors:  Sandeep K Singh; Mehmet Tevfik Dorak
Journal:  Front Public Health       Date:  2017-05-08

8.  Low T-cell subsets prior to development of virus-associated cancer in HIV-seronegative men who have sex with men.

Authors:  Anupriya Dutta; Hajime Uno; David R Lorenz; Steven M Wolinsky; Dana Gabuzda
Journal:  Cancer Causes Control       Date:  2018-10-12       Impact factor: 2.532

9.  Pre-diagnosis neutrophil-to-lymphocyte ratio and mortality in individuals who develop lung cancer.

Authors:  Carmen J Marsit; Jennifer A Doherty; Laurie Grieshober; Stefan Graw; Matt J Barnett; Gary E Goodman; Chu Chen; Devin C Koestler
Journal:  Cancer Causes Control       Date:  2021-07-08       Impact factor: 2.506

10.  Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy.

Authors:  Wangqiang Jia; Long Yuan; Hongyan Ni; Benling Xu; Peng Zhao
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.